Overview
Gene (OMIM No.) |
|
Function of gene/protein |
|
Clinical phenotype (OMIM phenotype no.) | |
Inheritance |
|
Ocular features |
|
Systemic features | Myopathy, myofibrillar, 2:
|
Key investigations |
|
Molecular diagnosis | Next generation sequencing
|
Management | OcularSystemic
|
Therapies under research |
|
Further information |
Additional information
The phenotypes associated with CYRAB mutations are clinically heterogenous. A partial genotype-phenotype relationship can be observed.
Heterozygous (autosomal dominant) variants in different locations of the CRYAB gene can result in different phenotypes. Mutations in exon 1 (a 1-base pair deletion 450delA and p.Pro20Ser) are associated with an isolated cataract phenotype[1,2], while mutations in exon 3 can cause isolated cataract (p.Asp140Asn)[3], isolated late-onset mild dilated cardiomyopathy (p.Arg157His and p.Gly154Ser)[4,5]or a multisystemic muscular dystrophy with adult-onset lens opacities (p.Asp109His, p.Arg120Gly and p.Gly151Ter).[6-8]
Autosomal recessive missense mutation (p.Arg56Trp) of CRYAB causes isolated cataract[9] while the truncating mutation p.Ser21Ala, a founder mutation reported in Canadian aboriginals of Cree descent, is associated with a severe phenotype called fatal hypertonic infantile muscular dystrophy (OMIM #613869).[10] This condition is characterised by early (first few weeks of life) and rapidly progressive limb and axial muscle stiffness, with increasing severe respiratory difficulty resulting in death before 3 years of age.
References
- Berry V, Francis P, Reddy MA, et al. Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans. Am J Hum Genet. 2001;69(5):1141‐1145
- Liu M, Ke T, Wang Z, et al. Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family. Invest Ophthalmol Vis Sci. 2006;47(8):3461‐3466
- Liu Y, Zhang X, Luo L, et al. A novel alphaB-crystallin mutation associated with autosomal dominant congenital lamellar cataract. Invest Ophthalmol Vis Sci. 2006;47(3):1069‐1075
- Inagaki N, Hayashi T, Arimura T, et al. Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun. 2006;342(2):379-386
- Pilotto A, Marziliano N, Pasotti M, Grasso M, Costante AM, Arbustini E. alphaB-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands. Biochem Biophys Res Commun. 2006;346(4):1115-1117
- Vicart P, Caron A, Guicheney P, et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998;20(1):92-95
- Selcen D, Engel AG. Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol. 2003;54(6):804-810
- Sacconi S, Féasson L, Antoine JC, et al. A novel CRYAB mutation resulting in multisystemic disease. Neuromuscul Disord. 2012;22(1):66‐72
- Safieh LA, Khan AO, Alkuraya FS. Identification of a novel CRYAB mutation associated with autosomal recessive juvenile cataract in a Saudi family. Mol Vis. 2009;15:980‐984
- Del Bigio MR, Chudley AE, Sarnat HB, et al. Infantile muscular dystrophy in Canadian aboriginals is an αB-crystallinopathy. Ann Neurol. 2011;69(5):866-871
- Chávez Zobel AT, Loranger A, Marceau N, Thériault JR, Lambert H, Landry J. Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G alphaB-crystallin mutant. Hum Mol Genet. 2003;12(13):1609‐1620
- Wang X, Osinska H, Klevitsky R, et al. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ Res. 2001;89(1):84-91